{"url_path":"/sec/mdxg/8-k/2026-08-11/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"8-K/A","doc_date":"2026-08-11","source_url":"https://www.sec.gov/Archives/edgar/data/1376339/0001376339-26-000082-index.html","accession_number":"0001376339-26-000082","cik":"0001376339","ticker":"MDXG","issuer_name":"MIMEDX GROUP, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1376339/0001376339-26-000082-index.html","primary_entity_key":"0001376339","primary_entity_name":"MIMEDX GROUP, INC."},"word_count":465,"has_tables":true,"body_markdown":"mdxg-20260729\n0001376339true00013763392026-07-292026-07-29\n\nUNITED STATES\n\nSECURITIES AND EXCHANGE COMMISSION\n\nWASHINGTON, DC 20549\n\n____________________\n\nFORM 8-K/A\n(Amendment No. 1)\n____________________\n\nCURRENT REPORT\n\nPURSUANT TO SECTION 13 OR 15(d)\n\nOF THE SECURITIES EXCHANGE ACT OF 1934\n\nDate of Report (Date of earliest event reported): July 29, 2026\n\nMIMEDX GROUP, INC.\n\n(Exact name of registrant as specified in charter)\n\nFlorida001-3588726-2792552\n\n(State or other jurisdiction(Commission(IRS Employer\n\nof incorporation)File Number)Identification No.)\n\n1775 West Oak Commons Ct., NE, Marietta GA 30062\n\n(Address of principal executive offices) (Zip Code)\n\nRegistrant’s telephone number, including area code: (770) 651-9100\n\n____________________\n\nCheck the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):\n\n☒Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)\n\n☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)\n\n☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))\n\n☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))\n\nSecurities registered pursuant to Section 12(b) of the Act:\n\nTitle of each classTrading Symbol(s)Name of each exchange\non which registered\n\nCommon Stock, $0.001 par value per shareMDXGThe Nasdaq Stock Market LLC\n\nIndicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).\n\nEmerging growth company ☐\n\nIf an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐\n\nEXPLANATORY NOTE\n\nThis Amendment No. 1 (this “Amendment”) to the Current Report on Form 8-K originally filed by MiMedx Group, Inc., with the Securities and Exchange Commission on July 29, 2026 (the “Original Report”) is being filed to amend and restate the Original Report. The only change to the Original Report is to correct an error in Item 1.01 of the Original Report that inadvertently reported (i) the amount of the termination fee payable by Sanara MedTech Inc. in certain circumstances as $22,540,785.00 as opposed to the correct termination fee of $9,660,336.00 and (ii) the amount of the termination fee payable by MiMedx Group, Inc. in certain circumstances as $9,660,336.00 as opposed to the correct termination fee of $22,540,785.00.\n\nExcept as described above, this Amendment does not amend, update or change any other disclosures in the Original Report. In addition, the information contained in this Amendment does not reflect events occurring after the filing of the Original Report and does not modify or update the disclosures therein, except as specifically identified above."}